One small 2006 trial of just 40 kids in Iran may have tipped the scales in favour of prescribing Prozac for childhood depression. When researchers removed its suspicious data from major medical reviews, Prozac's huge advantage over placebo vanished, and the team say guidelines now need a fresh look.